Updated Perspectives on the Neurobiology of Substance Use Disorders Using Neuroimaging

References

• Eastlack SC, Cornett EM, Kaye AD. Kratom-pharmacology, clinical implications, and outlook: a comprehensive review. Pain Ther. 2020;9(1):55–69. doi:10.1007/s40122-020-00151-x
   PubMed Web of Science ®Google Scholar
• Urits I, Charipova K, Gress K, et al. Adverse effects of recreational and medical cannabis. Psychopharmacol Bull. 2021;51(1):94–109.
   PubMedGoogle Scholar
• Hayes A, Herlinger K, Paterson L, Lingford-Hughes A. The neurobiology of substance use and addiction: evidence from neuroimaging and relevance to treatment. B J Psych Adv. 2020;26(6):367–378. doi:10.1192/bja.2020.68
   Google Scholar
• Edinoff AN, Kaufman SE, Green KM, et al. Methamphetamine use: a narrative review of adverse effects and related toxicities. Health Psychol Res. 2022;10(3):38161. doi:10.52965/001c.38161
   PubMed Web of Science ®Google Scholar
• Ceceli AO, Bradberry CW, Goldstein RZ. The neurobiology of drug addiction: cross-species insights into the dysfunction and recovery of the prefrontal cortex. Neuropsychopharmacology. 2022;47(1):276–291. doi:10.1038/s41386-021-01153-9
   PubMed Web of Science ®Google Scholar
• Sagrera CE, Alderman L, Goeders NE, Murnane KS. Elucidating the role of trauma and significant life stress in the disease of addiction may provide new targets for medication development. CNS Neurol Disord Drug Targets. 2022. doi:10.2174/1871527321666220511145230
   Web of Science ®Google Scholar
• McPherson P, Alderman LL, Temple J, et al. Teen Advisory Council Survey’s factors associated with self-harming thoughts. Front Psychiatry. 2022;13:851477. doi:10.3389/fpsyt.2022.851477
   PubMed Web of Science ®Google Scholar
• Volkow ND, Boyle M. Neuroscience of addiction: relevance to prevention and treatment. Am J Psychiatry. 2018;175(8):729–740. doi:10.1176/appi.ajp.2018.17101174
   PubMed Web of Science ®Google Scholar
• Fowler JS, Volkow ND, Kassed CA, Chang L. Imaging the addicted human brain. Sci Pract Perspect. 2007;3(2):4–16. doi:10.1151/spp07324
   PubMedGoogle Scholar
• Henry PK, Murnane KS, Votaw JR, Howell LL. Acute brain metabolic effects of cocaine in rhesus monkeys with a history of cocaine use. Brain Imaging Behav. 2010;4(3–4):212–219. doi:10.1007/s11682-010-9100-5
   PubMed Web of Science ®Google Scholar
• Howell LL, Murnane KS. Nonhuman primate neuroimaging and the neurobiology of psychostimulant addiction. Ann N Y Acad Sci. 2008;1141(1):176–194. doi:10.1196/annals.1441.023
   PubMedGoogle Scholar
• Murnane KS. The renaissance in psychedelic research: what do preclinical models have to offer. Prog Brain Res. 2018;242:25–67. doi:10.1016/bs.pbr.2018.08.003
   PubMed Web of Science ®Google Scholar
• Koob GF, Volkow ND. Neurobiology of addiction: a neurocircuitry analysis. Lancet Psychiatry. 2016;3(8):760–773. doi:10.1016/S2215-0366(16)00104-8
   PubMed Web of Science ®Google Scholar
• Heilig M, MacKillop J, Martinez D, Rehm J, Leggio L, Vanderschuren LJMJ. Addiction as a brain disease revised: why it still matters, and the need for consilience. Neuropsychopharmacology. 2021;46(10):1715–1723. doi:10.1038/s41386-020-00950-y
   PubMed Web of Science ®Google Scholar
• Volkow ND, Koob GF, McLellan AT, Longo DL. Neurobiologic advances from the brain disease model of addiction. N Engl J Med. 2016;374(4):363–371. doi:10.1056/NEJMra1511480
   PubMed Web of Science ®Google Scholar
• Koob GF, Caine B, Markou A, Pulvirenti L, Weiss F. Role for the mesocortical dopamine system in the motivating effects of cocaine. NIDA Res Monogr. 1994;145:1–18.
   PubMedGoogle Scholar
• Di Chiara G. A motivational learning hypothesis of the role of mesolimbic dopamine in compulsive drug use. J Psychopharmacol Oxf Engl. 1998;12(1):54–67. doi:10.1177/026988119801200108
   PubMed Web of Science ®Google Scholar
• Volkow ND, Wang GJ, Fowler JS, Tomasi D, Telang F. Addiction: beyond dopamine reward circuitry. Proc Natl Acad Sci U S A. 2011;108(37):15037–15042. doi:10.1073/pnas.1010654108
   PubMed Web of Science ®Google Scholar
• Murnane KS, Howell LL. Neuroimaging and drug taking in primates. Psychopharmacology. 2011;216(2):153–171. doi:10.1007/s00213-011-2222-7
   PubMed Web of Science ®Google Scholar
• Volkow ND, Muenke M. The genetics of addiction. Hum Genet. 2012;131(6):773–777. doi:10.1007/s00439-012-1173-3
   PubMed Web of Science ®Google Scholar
• Tiffany ST, Carter BL, Singleton EG. Challenges in the manipulation, assessment and interpretation of craving relevant variables. Addict Abingdon Engl. 2000;95(Suppl 2):S177–S187. doi:10.1080/09652140050111753
   PubMedGoogle Scholar
• Mitchell JM, O’Neil JP, Janabi M, Marks SM, Jagust WJ, Fields HL. Alcohol consumption induces endogenous opioid release in the human orbitofrontal cortex and nucleus accumbens. Sci Transl Med. 2012;4(116):116ra6. doi:10.1126/scitranslmed.3002902
   PubMed Web of Science ®Google Scholar
• Caine SB, Negus SS, Mello NK, et al. Role of dopamine D2-like receptors in cocaine self-administration: studies with D2 receptor mutant mice and novel D2 receptor antagonists. J Neurosci. 2002;22(7):2977–2988. doi:10.1523/JNEUROSCI.22-07-02977.2002
   PubMed Web of Science ®Google Scholar
• Self DW, Genova LM, Hope BT, Barnhart WJ, Spencer JJ, Nestler EJ. Involvement of cAMP-dependent protein kinase in the nucleus accumbens in cocaine self-administration and relapse of cocaine-seeking behavior. J Neurosci. 1998;18(5):1848–1859. doi:10.1523/JNEUROSCI.18-05-01848.1998
   PubMed Web of Science ®Google Scholar
• Koob GF, Le Moal M. Plasticity of reward neurocircuitry and the “dark side” of drug addiction. Nat Neurosci. 2005;8(11):1442–1444. doi:10.1038/nn1105-1442
   PubMed Web of Science ®Google Scholar
• Garavan H, Pankiewicz J, Bloom A, et al. Cue-induced cocaine craving: neuroanatomical specificity for drug users and drug stimuli. Am J Psychiatry. 2000;157(11):1789–1798. doi:10.1176/appi.ajp.157.11.1789
   PubMed Web of Science ®Google Scholar
• Koob GF, Bloom FE. Cellular and molecular mechanisms of drug dependence. Science. 1988;242(4879):715–723. doi:10.1126/science.2903550
   PubMed Web of Science ®Google Scholar
• Volkow ND, Wang GJ, Fowler JS, et al. Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature. 1997;386(6627):830–833. doi:10.1038/386830a0
   PubMed Web of Science ®Google Scholar
• Risinger RC, Salmeron BJ, Ross TJ, et al. Neural correlates of high and craving during cocaine self-administration using BOLD fMRI. NeuroImage. 2005;26(4):1097–1108. doi:10.1016/j.neuroimage.2005.03.030
   PubMed Web of Science ®Google Scholar
• Milella MS, Fotros A, Gravel P, et al. Cocaine cue–induced dopamine release in the human prefrontal cortex. J Psychiatry Neurosci. 2016;41(5):322–330. doi:10.1503/jpn.150207
   PubMed Web of Science ®Google Scholar
• Fowler JS, Volkow ND. PET imaging studies in drug abuse. J Toxicol Clin Toxicol. 1998;36(3):163–174. doi:10.3109/15563659809028936
   PubMed Web of Science ®Google Scholar
• Volkow ND, Hitzemann R, Wang GJ, et al. Long-term frontal brain metabolic changes in cocaine abusers. Synap N Y N. 1992;11(3):184–190. doi:10.1002/syn.890110303
   PubMed Web of Science ®Google Scholar
• Volkow ND, Fowler JS, Wang GJ. The addicted human brain: insights from imaging studies. J Clin Invest. 2003;111(10):1444–1451. doi:10.1172/JCI18533
   PubMed Web of Science ®Google Scholar
• Amen DG, Willeumier K, Johnson R. The clinical utility of brain SPECT imaging in process addictions. J Psychoactive Drugs. 2012;44(1):18–26. doi:10.1080/02791072.2012.660101
   PubMed Web of Science ®Google Scholar
• Malison RT, Best SE, van Dyck CH, et al. Elevated striatal dopamine transporters during acute cocaine abstinence as measured by [123I] beta-CIT SPECT. Am J Psychiatry. 1998;155(6):832–834. doi:10.1176/ajp.155.6.832
   PubMed Web of Science ®Google Scholar
• Volkow ND, Fowler JS, Wang GJ. Positron emission tomography and single-photon emission computed tomography in substance abuse research. Semin Nucl Med. 2003;33(2):114–128. doi:10.1053/snuc.2003.127300
   PubMed Web of Science ®Google Scholar
• Murray DE, Durazzo TC, Schmidt TP, et al. Regional cerebral blood flow in opiate dependence relates to substance use and neuropsychological performance. Addict Biol. 2018;23(2):781–795. doi:10.1111/adb.12523
   PubMed Web of Science ®Google Scholar
• Liu X, Matochik JA, Cadet JL, London ED. Smaller volume of prefrontal lobe in polysubstance abusers: a magnetic resonance imaging study. Neuropsychopharmacol. 1998;18(4):243–252. doi:10.1016/S0893-133X(97)00143-7
   PubMed Web of Science ®Google Scholar
• Thompson PM, Hayashi KM, Simon SL, et al. Structural abnormalities in the brains of human subjects who use methamphetamine. J Neurosci. 2004;24(26):6028–6036. doi:10.1523/JNEUROSCI.0713-04.2004
   PubMed Web of Science ®Google Scholar
• Volkow ND, Fowler JS, Wolf AP, et al. Changes in brain glucose metabolism in cocaine dependence and withdrawal. Am J Psychiatry. 1991;148(5):621–626.
   PubMed Web of Science ®Google Scholar
• Wexler BE, Gottschalk CH, Fulbright RK, et al. Functional magnetic resonance imaging of cocaine craving. Am J Psychiatry. 2001;158(1):86–95. doi:10.1176/appi.ajp.158.1.86
   PubMed Web of Science ®Google Scholar
• Paulus MP, Hozack NE, Zauscher BE, et al. Behavioral and functional neuroimaging evidence for prefrontal dysfunction in methamphetamine-dependent subjects. Neuropsychopharmacol. 2002;26(1):53–63. doi:10.1016/S0893-133X(01)00334-7
   PubMed Web of Science ®Google Scholar
• Kaufman JN, Ross TJ, Stein EA, Garavan H. Cingulate hypoactivity in cocaine users during a GO-NOGO task as revealed by event-related functional magnetic resonance imaging. J Neurosci. 2003;23(21):7839–7843. doi:10.1523/JNEUROSCI.23-21-07839.2003
   PubMed Web of Science ®Google Scholar
• Ray S, Hanson C, Hanson SJ, Bates ME. fMRI BOLD response in high-risk college students (part 1): during exposure to alcohol, marijuana, polydrug and emotional picture cues. Alcohol Alcohol Oxf Oxfs. 2010;45(5):437–443. doi:10.1093/alcalc/agq042
   PubMed Web of Science ®Google Scholar
• Martz ME, Hart T, Heitzeg MM, Peltier SJ. Neuromodulation of brain activation associated with addiction: a review of real-time fMRI neurofeedback studies. NeuroImage Clin. 2020;27:102350. doi:10.1016/j.nicl.2020.102350
   PubMed Web of Science ®Google Scholar
• Ernst T, Chang L, Leonido-Yee M, Speck O. Evidence for long-term neurotoxicity associated with methamphetamine abuse: a 1H MRS study. Neurology. 2000;54(6):1344–1349. doi:10.1212/WNL.54.6.1344
   PubMed Web of Science ®Google Scholar
• Chang L, Ernst T, Strickland T, Mehringer CM. Gender effects on persistent cerebral metabolite changes in the frontal lobes of abstinent cocaine users. Am J Psychiatry. 1999;156(5):716–722. doi:10.1176/ajp.156.5.716
   PubMed Web of Science ®Google Scholar
• Kohut SJ, Kaufman MJ. Magnetic resonance spectroscopy studies of substance use disorders: current landscape and potential future directions. Pharmacol Biochem Behav. 2021;200:173090. doi:10.1016/j.pbb.2020.173090
   PubMed Web of Science ®Google Scholar
• Alper KR, Chabot RJ, Kim AH, Prichep LS, John ER. Quantitative EEG correlates of crack cocaine dependence. Psychiatry Res. 1990;35(2):95–105. doi:10.1016/0925-4927(90)90013-V
   PubMed Web of Science ®Google Scholar
• Costa L, Bauer L. Quantitative electroencephalographic differences associated with alcohol, cocaine, heroin and dual-substance dependence. Drug Alcohol Depend. 1997;46(1–2):87–93. doi:10.1016/S0376-8716(97)00058-6
   PubMed Web of Science ®Google Scholar
• Sokhadze TM, Cannon RL, Trudeau DL. EEG biofeedback as a treatment for substance use disorders: review, rating of efficacy, and recommendations for further research. Appl Psychophysiol Biofeedback. 2008;33(1):1–28. doi:10.1007/s10484-007-9047-5
   PubMed Web of Science ®Google Scholar
• Stewart JL, May AC. Electrophysiology for addiction medicine: from methodology to conceptualization of reward deficits. Prog Brain Res. 2016;224:67–84.
   PubMed Web of Science ®Google Scholar
• Houston RJ, Schlienz NJ. Event-related potentials as biomarkers of behavior change mechanisms in substance use disorder treatment. Biol Psychiatry Cogn Neurosci Neuroimaging. 2018;3(1):30–40. doi:10.1016/j.bpsc.2017.09.006
   PubMedGoogle Scholar
• Bach P, de Timary P, Gründer G, Cumming P. Molecular imaging studies of alcohol use disorder. Curr Top Behav Neurosci. 2023;2023:1–31.
   Google Scholar
• Soto-Montenegro ML, García-Vázquez V, Lamanna-Rama N, López-Montoya G, Desco M, Ambrosio E. Neuroimaging reveals distinct brain glucose metabolism patterns associated with morphine consumption in Lewis and Fischer 344 rat strains. Sci Rep. 2022;12(1):4643. doi:10.1038/s41598-022-08698-9
   PubMed Web of Science ®Google Scholar
• Deng R, Yang X, Meng Y-J, et al. Data-driven study on resting-state functional magnetic resonance imaging during early abstinence of alcohol dependence in male patients and its predictive value for relapse. BMC Psychiatry. 2022;22(1):143. doi:10.1186/s12888-022-03782-w
   PubMed Web of Science ®Google Scholar
• Bralet MC, Mitelman SA, Goodman CR, Lincoln S, Hazlett EA, Buchsbaum MS. Fluorodeoxyglucose positron emission tomography scans in patients with alcohol use disorder. Alcohol Clin Exp Res. 2022;46(6):994–1010. doi:10.1111/acer.14845
   PubMedGoogle Scholar
• Ersche KD, Meng C, Ziauddeen H, et al. Brain networks underlying vulnerability and resilience to drug addiction. Proc Natl Acad Sci. 2020;117(26):15253–15261. doi:10.1073/pnas.2002509117
   PubMed Web of Science ®Google Scholar
• Murnane KS, Gopinath KS, Maltbie E, Daunais JB, Telesford QK, Howell LL. Functional connectivity in frontal-striatal brain networks and cocaine self-administration in female rhesus monkeys. Psychopharmacology. 2015;232(4):745–754. doi:10.1007/s00213-014-3709-9
   PubMed Web of Science ®Google Scholar
• Murnane KS, Howell LL. Development of an apparatus and methodology for conducting functional magnetic resonance imaging (fMRI) with pharmacological stimuli in conscious rhesus monkeys. J Neurosci Methods. 2010;191(1):11–20. doi:10.1016/j.jneumeth.2010.06.001
   PubMed Web of Science ®Google Scholar
• Murnane KS, Winschel J, Schmidt KT, et al. Serotonin 2A receptors differentially contribute to abuse-related effects of cocaine and cocaine-induced nigrostriatal and mesolimbic dopamine overflow in nonhuman primates. J Neurosci. 2013;33(33):13367–13374. doi:10.1523/JNEUROSCI.1437-13.2013
   PubMed Web of Science ®Google Scholar
• Murnane KS. Serotonin 2A receptors are a stress response system: implications for post-traumatic stress disorder. Behav Pharmacol. 2019;30(2 and 3–Spec Issue):151–162. doi:10.1097/FBP.0000000000000459
   PubMed Web of Science ®Google Scholar
• Hampton WH, Hanik IM, Olson IR. Substance abuse and white matter: findings, limitations, and future of diffusion tensor imaging research. Drug Alcohol Depend. 2019;197:288–298. doi:10.1016/j.drugalcdep.2019.02.005
   PubMed Web of Science ®Google Scholar
• Bell RP, Foxe JJ, Nierenberg J, Hoptman MJ, Garavan H. Assessing white matter integrity as a function of abstinence duration in former cocaine-dependent individuals. Drug Alcohol Depend. 2011;114(2–3):159–168. doi:10.1016/j.drugalcdep.2010.10.001
   PubMed Web of Science ®Google Scholar
• Pando-Naude V, Toxto S, Fernandez-Lozano S, Parsons CE, Alcauter S, Garza-Villarreal EA. Gray and white matter morphology in substance use disorders: a neuroimaging systematic review and meta-analysis. Transl Psychiatry. 2021;11(1):1–18. doi:10.1038/s41398-020-01128-2
   PubMed Web of Science ®Google Scholar
• Devoto F, Zapparoli L, Spinelli G, Scotti G, Paulesu E. How the harm of drugs and their availability affect brain reactions to drug cues: a meta-analysis of 64 neuroimaging activation studies. Transl Psychiatry. 2020;10(1):1–11. doi:10.1038/s41398-020-01115-7
   PubMed Web of Science ®Google Scholar
• Terem I, Dang L, Champagne A, et al. 3D amplified MRI (aMRI). Magn Reson Med. 2021;86(3):1674–1686. doi:10.1002/mrm.28797
   PubMed Web of Science ®Google Scholar
• Terem I, Ni WW, Goubran M, et al. Revealing sub-voxel motions of brain tissue using phase-based amplified MRI (aMRI). Magn Reson Med. 2018;80(6):2549–2559. doi:10.1002/mrm.27236
   PubMed Web of Science ®Google Scholar
• Siemens healthineers USA [Internet]; 2023. Available from: https://www.siemens-healthineers.com/en-us. Accessed June 27, 2023.
   Google Scholar
• Two new high-end MRI scanners for clinical and scientific use presented [Internet]; 2023. Available from: https://healthcare-in-europe.com/en/news/siemens-high-end-mri-scanners-clinical-scientific-use.html. Accessed June 27, 2023.
   Google Scholar
• Siemens healthineers introduces new mobile magnetic resonance imaging scanner Magnetom Viato.Mobile [Internet]; 2023. Available from: https://www.siemens-healthineers.com/press/releases/magnetom-viato-mobile. Accessed June 27, 2023.
   Google Scholar
• Photon counting CT [Internet]; 2023. Available from: https://www.siemens-healthineers.com/en-us/computed-tomography/technologies-and-innovations/photon-counting-ct. Accessed June 27, 2023.
   Google Scholar
• Toi PT, Jang HJ, Min K, et al. In vivo direct imaging of neuronal activity at high temporospatial resolution. Science. 2022;378(6616):160–168. doi:10.1126/science.abh4340
   PubMed Web of Science ®Google Scholar
• Hodono S, Rideaux R, van Kerkoerle T, Cloos MA. Initial experiences with direct imaging of neuronal activity (DIANA) in humans [Internet]. arXiv; 2023. Available from: http://arxiv.org/abs/2303.00161. Accessed June 27, 2023.
   Google Scholar
• Boyle AJ, Gaudet VC, Black SE, Vasdev N, Rosa-Neto P, Zukotynski KA. Artificial intelligence for molecular neuroimaging. Ann Transl Med. 2021;9(9):822. doi:10.21037/atm-20-6220
   PubMed Web of Science ®Google Scholar
• Yang L, Du Y, Yang W, Liu J. Machine learning with neuroimaging biomarkers: application in the diagnosis and prediction of drug addiction. Addict Biol. 2023;28(2):e13267. doi:10.1111/adb.13267
   PubMed Web of Science ®Google Scholar
• Monsour R, Dutta M, Mohamed AZ, Borkowski A, Viswanadhan NA. Neuroimaging in the era of artificial intelligence: current applications. Fed Pract. 2022;39(Suppl 1):S14–S20. doi:10.12788/fp.0231
   PubMedGoogle Scholar
• Mill RD, Winfield EC, Cole MW, Ray S. Structural MRI and functional connectivity features predict current clinical status and persistence behavior in prescription opioid users. NeuroImage Clin. 2021;30:102663. doi:10.1016/j.nicl.2021.102663
   PubMed Web of Science ®Google Scholar
• Mete M, Sakoglu U, Spence JS, Devous MD, Harris TS, Adinoff B. Successful classification of cocaine dependence using brain imaging: a generalizable machine learning approach. BMC Bioinform. 2016;17(Suppl 13):357. doi:10.1186/s12859-016-1218-z
   PubMedGoogle Scholar
• Chen Z, Liu X, Yang Q, et al. Evaluation of risk of bias in neuroimaging-based artificial intelligence models for psychiatric diagnosis. JAMA Netw Open. 2023;6(3):e231671. doi:10.1001/jamanetworkopen.2023.1671
   PubMedGoogle Scholar
• Gowin JL, Ernst M, Ball T, et al. Using neuroimaging to predict relapse in stimulant dependence: a comparison of linear and machine learning models. NeuroImage Clin. 2019;11(21):101676. doi:10.1016/j.nicl.2019.101676
   Google Scholar